A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement

Bone and Joint Journal

Volumn 96 B, Issue 8, 2014, Pages 1005-1015

  Alshryda, Sattar ^a   Sukeik, M ^a,b   Sarda, P ^a,c   Blenkinsopp, J ^a,d   Haddad, F S ^a,b   Mason, J M ^a,e  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c MEDWAY MARITIME HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^e DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; KETOROLAC; LOW MOLECULAR WEIGHT HEPARIN; NORADRENALIN; ROPIVACAINE; TRANEXAMIC ACID;

BLOOD TRANSFUSION; CARDIOVASCULAR RISK; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LENGTH OF STAY; META ANALYSIS; OPERATIVE BLOOD LOSS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

BLOOD LOSS; BLOOD TRANSFUSION; TOPICAL; TRANEXAMIC ACID;

ADMINISTRATION, TOPICAL; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TRANEXAMIC ACID; VENOUS THROMBOSIS;

EID: 84906351131     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.96B8.33745     Document Type: Review

References (58)

1. Aderinto J, Brenkel IJ. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg [Br] 2004;86-B:970-973. (Pubitemid 39255858)
2. Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001;72:442-448. (Pubitemid 33043582)
3. Baker C, Hartley J, Lumley M, et al. Audit of blood use in orthopaedic surgery: comparative report; March 2005:2-14.
4. Li B, Wen Y, Wu H, et al. The effect of tourniquet use on hidden blood loss in total knee arthroplasty. Int Orthop 2009;33:1263-1268.
5. Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account. Knee 2000;7:151-155. (Pubitemid 30601705)
6. Sorin A, Claeys MA, Jansen A, D'Haese J, Camu F. Reduction of blood loss by tranexamic acid in total knee replacement. J Bone Joint Surg [Br]. 1999; 81-B(SupplII):234.
7. Klein HG. Allogeneic transfusion risks in the surgical patient. Am J Surg 1995;170(6ASuppl):21S-26S.
8. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-1690. (Pubitemid 26193619)
9. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg [Br] 2011;93-B:39-46.
10. Alshryda S, Sarda P, Sukeik M, et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg [Br] 2011;93-B:1577-1585.
11. Wong J, Abrishami A, El Beheiry H, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg [Am] 2010;92-A:2503-2513.
12. Dunn CJ, Goa KL. Tranexamic acid: A review of its use and other indications. Drugs 1999;57:1005-1032. (Pubitemid 29313210)
13. Alessandrini F, De Bonis M, Cavaliere F, et al. Topical use of tranexamic acid in coronary artery bypass operations: a double blind prospective, randomised placebo - controlled study. J Cardiovascular surg, 2000;119: 575-580. (Pubitemid 30146538)
14. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. http://handbook.cochrane.org/ (date last accessed 07 May 2014).
15. Murray DW, Fitzpatrick R, Rogers K, et al. The use of the Oxford hip and knee scores. J Bone Joint Surg [Br] 2007; 89:1010-1014. (Pubitemid 47492792)
16. Oppe M, Rabin R, de Charro F. (on behalf of the EuroQol Group) EQ-5D User Guide. Vol. V 1.0. 2007:2-22.
17. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
18. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
19. Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee 2013;20:300-309.
20. Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical Tranexamic Acid Reduces Transfusion Rates in Total Hip and Knee Arthroplasty. J Arthroplasty 2014;29:681-684.
21. Konig G, Hamlin BR, Waters JH. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty 2013;28:1473-1476.
22. Krohn CD, Sørensen R, Lange JE, et al. Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery. Eur J Surg Suppl 2003;588:57-61. (Pubitemid 36918759)
23. Chimento GF, Huff T, Ochsner JL Jr, et al. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;28(8Suppl):74-77.
24. Ipema HJ, Tanzi MG. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother 2012;46:97-107.
25. Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev 2013;7:CD010562.
26. Molloy DO, Archbold HA, Ogonda L, et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg [Br] 2007;89-B:306-309. (Pubitemid 46563903)
27. Onodera T, Majima T, Sawaguchi N, et al. Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J Arthroplasty 2012;27:105-108.
28. Abrishami A. Timing and volume of topical tranexamic acid administration for post-operative blood loss in total knee arthroplasty. [abstract] Can J Anesth/J Can Anesth 2010;57-S142.
29. Van Elst CE, Simon JP, Corten K, Vanbiervliet J. The effect of topical application of tranexamic acid in total hip arthroplasty through the direct anterior apporach. American Academy of Orthopaedic Surgeons Annual Meeting [presentation abstract] 2013.
30. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012;470:2605-2612.
31. Roy SP, Tanki UF, Dutta A, Jain SK, Nagi ON. Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2012;20:2494-2501.
32. Alshryda S, Mason J, Vaghela M, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg [Am] 2013;95-A:1961-1968.
33. Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;28(8Suppl):78-82.
34. Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013;21:1869-1874.
35. Ishida K, Tsumura N, Kitagawa A, et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011;35:1639-1645.
36. Sa-Ngasoongsong P, Channoom T, Kawinwonggowit V, et al. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthop Rev (Pavia) 2011;3:12.
37. Sa-Ngasoongsong P, Wongsak S, Chanplakorn P, et al. Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. : C Musculoskelet Disord 2013;14:340.
38. Canata GL, Casale V, Chiey A. Management of postoperative pain and bleeding in knee replacement. J Orthopaed Traumatol 2012;3(Suppl 1):S25-S55.
39. Alshryda S, Mason J, Sarda P, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg [Am] 2013;95-A:1969-1974.
40. Martin JG, Cassatt KB, Kincaid-Cinnamon KA, et al. Topical Administration of Tranexamic Acid in Primary Total Hip and Total Knee Arthroplasty. J Arthroplasty 2014;29:889-894.
41. Alvarez JC, Santiveri FX, Ramos I, et al. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion. 2008;48:519-525. (Pubitemid 351294580)
42. Camarasa MA, Ollé G, Serra-Prat M, et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth. 2006;96:576-582.
43. Ellis MH, Fredman B, Zohar E, Ifrach N, Jedeikin R. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth. 2001;13:509-513. (Pubitemid 33026483)
44. Engel JM, Hohaus T, Ruwoldt R, et al. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg. 2001;92:775-780. (Pubitemid 32185127)
45. Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth. 2003;90:596-599. (Pubitemid 36592332)
46. Hiippala S, Strid L, Wennerstrand M, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth. 1995;74:534-537.
47. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg . 1997;84:839-844. (Pubitemid 27147712)
48. Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee. 2006;13:106-110. (Pubitemid 43374933)
49. Tanaka N, Sakahashi H, Sato E, et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg [Br]. 2001;83:702-705. (Pubitemid 32700674)
50. Veien M, Sørensen JV, Madsen F, Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand. 2002;46:1206-1211. (Pubitemid 35341889)
51. Zohar E, Fredman B, Ellis MH, et al. A comparative study of the postoperative allogeneic blood-sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion 2001;41:1285-1289. (Pubitemid 33000967)
52. Jansen AJ, Andreica S, Claeys M, et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999;83:596-601. (Pubitemid 29458825)
53. Kakar PN, Gupta N, Govil P, Shah V. Efficacy and safety of tranexamic acid in control of bleeding following TKR: a randomized clinical trial. Indian J Anaesth 2009;53:667-671.
54. Ido K, Neo M, Asada Y, et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 2000;120:518-520.
55. Huang Z, Ma J, Pei F, et al. Meta-analysis of temporary versus no clamping in TKA. Orthopedics 2013;36:543-550.
56. Li T, Zhuang Q, Weng X, Zhou L, Bian Y. Non-continuous versus continuous wound drainage after total knee arthroplasty: a meta-analysis. Int Orthop 2014;38:361-371.
57. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007;4:CD001886.
58. De Bonis M, Cavaliere F, Alessandrini F, et al. Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg 2000;119:575-580. (Pubitemid 30146538)